2025
Robotic-Assisted Percutaneous Coronary Intervention: Final Results of the PRECISION and PRECISION GRX Studies
Mahmud E, Madder R, Wohns D, Schussler J, Salisbury A, Campbell P, Patel T, Lombardi W, Nicholson W, Parikh M, Kelm N, Waksman R, Lansky A, Weisz G. Robotic-Assisted Percutaneous Coronary Intervention: Final Results of the PRECISION and PRECISION GRX Studies. Journal Of The Society For Cardiovascular Angiography & Interventions 2025, 4: 103655. PMID: 40933108, PMCID: PMC12418459, DOI: 10.1016/j.jscai.2025.103655.Peer-Reviewed Original ResearchTechnical success rateR-PCIPercutaneous coronary interventionTechnical successClinical successSuccess rateCoronary interventionCalcific lesionsLack of clinical dataSymptomatic coronary artery diseaseClinical success rateSingle-arm studyAdverse cardiovascular eventsCoronary artery diseaseBifurcation lesionsManual PCIMulticenter experienceComplex lesion typePatient cohortCardiovascular eventsResidual stenosisClinical dataRobotic percutaneous coronary interventionArtery diseaseLesions
2024
Impact of HER2 low status on genomic signatures in triple negative breast cancer (TNBC).
Taylor M, Reddy S, Ashok Kumar P, Hariri D, Sokol E, Sivakumar S, Quintanilha J, Pavlick D, Levy M, Ross J, Lustberg M. Impact of HER2 low status on genomic signatures in triple negative breast cancer (TNBC). Journal Of Clinical Oncology 2024, 42: 1092-1092. DOI: 10.1200/jco.2024.42.16_suppl.1092.Peer-Reviewed Original ResearchTriple negative breast cancerComprehensive genomic profilingGenomic alterationsHER2 statusHER2 2Triple negative breast cancer groupGA frequencyReview of pathology specimensHER2 IHC expressionHER2-low statusHER2-low tumorsLack of clinical dataPD-L1 expressionTumor mutational burdenHER2 IHC scoreHER2 2+Negative breast cancerEvaluate genomic alterationsMann-Whitney U testPotential treatment optionStatistically significant differenceHER2 subgroupsPD-L1Immunotherapy biomarkersChi-square test
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply